Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.

Schreiner, Teri L; Miravalle, Augusto

Schreiner, Teri L; Miravalle, Augusto.

Afiliación

Schreiner TL; Department of Neurology, University of Colorado, Denver, CO, USA.

J Cent Nerv Syst Dis ; 4: 1-14, 2012.

Article en En | MEDLINE | ID: mdl-23650463

Palabras clave

BG12; EDSS; Interferon beta 1a (Avonex); Interferon beta 1a (Rebif); Interferon beta 1b (Betaseron); Laquinimod; MRI; Teriflunomide; cladribine; clinical trials; disability progression; fingolimod (Gilenya); glatiramer acetate (Copaxone); methylprednisolone; mitoxantrone (Novantrone); multiple sclerosis; natalizumab (Tysabri); progressive; relapse rate; relapsing and remitting; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google